U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-KSB

                TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                    FOR FISCAL YEAR ENDED DECEMBER 31, 2003.

                                    333-99101
                             Commission File Number

                              BODISEN BIOTECH, INC.

                 (Name of small business issuer in its charter)



          Delaware                                               98-0381367
          -------                                                ----------
State or other jurisdiction                                     IRS Employer
      of incorporation                                       Identification No.


               North Part of Xinquia Road, Yang Ling Agricultural
                    High-Tech Industries Demonstration Zone,
          Yang Ling, People's Republic of China, 712100, 86-29-87074957
          (Address and telephone number of principal executive offices)

Securities registered under Section 12(b) of the Exchange Act: None.

Securities registered under Section 12(g) of the Exchange Act: None.

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act, during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Check if disclosure of delinquent filers in response to Item 405 of Regulation
S-B is not contained in this form, and no disclosure will be contained, to the
best of registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-KSB or any amendment to
this Form 10-KSB. [X].

The registrant's revenues from continuing operations for the year ended December
31, 2003 were $9,783,784.

As of March 22, 2004, the aggregate market value of the common stock held by
non-affiliates computed by reference to the average bid and asked prices of such
stock was $25,551,099

As of March 22, 2004, the registrant had 15,268,000 shares of common stock, par
value $.0001 per share, outstanding.
<PAGE>
                                     PART I

ITEM 1. DESCRIPTION OF BUSINESS.

                           INTRODUCTION AND BACKGROUND

     We are incorporated under the laws of the state of Delaware and are
headquartered in the Shaanxi Province, People's Republic of China. We engage in
the business of manufacturing and marketing a brand of organic fertilizer to the
five leading agricultural provinces of China. We produce numerous proprietary
product lines, from pesticides to crop specific fertilizer. These products are
then marketed and sold to farmers throughout the 17 provinces of China. We
conduct research and development to further improve existing products and
develop new formulas and products.

     Prior to February 11, 2004, we were known as Stratabid.com, Inc. We were a
startup stage Internet based commercial mortgage origination business. We
operated primarily through our wholly-owned subsidiary, Stratabid.com Online
(B.C.) Ltd. which provided services throughout Canada. On February 11, 2004, we
entered into an Agreement and Plan of Merger whereby we acquired Bodisen
International, Inc., a Delaware corporation in a reverse merger. The Agreement
and Plan of Merger was closed on February 24, 2004. On February 25, 2004, we
sold our wholly-owned subsidiary, Stratabid.com Online to Derrek Wasson, our
former Chief Executive Officer. On March 1, 2004, we changed our name from
Stratabid.com, Inc. to Bodisen Biotech, Inc.

                                INDUSTRY OVERVIEW

     The organic fertilizer business in China is still in its infancy. Compared
with traditional chemical fertilizer, organic fertilizer is composed of natural
nutritional elements that enhance soil quality to increase crop yields, without
the chemical side effect of harming soil fertility. In relation to traditional
compound chemical fertilizer, organic compound fertilizer accelerates
reproduction of soil microbes to improve soil quality through the decomposition
of organic material. This soil microbe enhanced by organic fertilizer improves
the soil's retention of nitrogen. Moreover, this application can activate
dormant soil by increasing soil nitrites and moisture content that otherwise is
not enhanced by traditional chemical fertilizers. This process controls the
release of nutritional elements that enhances the quality, quantity and health
of crops. As a result of years of intensive farming, China's soil quality is low
compared to international standards; therefore it has been widely recognized
that organic fertilizer can be more effective than traditional chemical
fertilizer in stabilizing and enhancing soil quality. Based on these facts, and
the fact that organic fertilizer can be widely utilized, the market for organic
fertilizer is rapidly growing and the use of organic fertilizer has become
popular throughout China.

                                    PRODUCTS

We maintain over 60 package products, which are broken down into 3 product line
categories:

     1.   Organic Compound Fertilizer has been found in tests conducted by us
          with local area farmers in Shaanxi, which are further described in the
          "Marketing" description below, to increase yields within one planting
          season in a variety of crops including, wheat, maize, tobacco and
          various vegetable and fruit crops. Plants tend to easily absorb
          organic fertilizer without the side affects found in synthetic
          chemical fertilizer products, and this organic process strengthens
          photosynthesis, which improves the overall health of a plant in
          resisting drought and disease. The International Organization for
          Standardization or ISO has qualified our organic compound fertilizer
          products.

     2.   Liquid Fertilizer is a series of products which can be applied to
          grapes, pears, cucumbers, potatoes, watermelon, apples, oranges,
          asparagus, garlic and strawberries. By applying liquid fertilizer
          during the early stages of a plants development, plants absorb the key
          elements and nutrients of the fertilizer, which strengthen
          photosynthesis, improving the overall health of the plant and making
          it more resistant to disease. In addition, liquid fertilizer heightens
          the color and luster of fruits and vegetables and the overall quality
          of the end product.

     3.   Pesticides and Insecticides. Our pesticide products can be applied to
          fruit trees and vegetable crops and will help eliminate harmful pests
          that reduce overall crop yields. A sample of the pests that bring harm
          to crops in China include, but are not limited to; the peach fruit
          fly, white aphid, red aphid, red mite, cotton bollworm, maize mite,
          cabbage butterfly, leaf acaroids, pear mite, grain worm, wheat moth,
          and the millet fly.

                                       2
<PAGE>
     All of our products are mass-produced and distributed to the wholesalers
and distribution centers in the 17 provinces in which we do business. The
organic compound fertilizer and liquid fertilizer are used mainly in the first
half of each year. The busy periods of the farmers from south China and north
China are different, so the seasonal sales of the organic compound fertilizer
and liquid fertilizer vary. With regards to pesticide, the busy period for this
product is from April to August of each year. Our wholesalers sell the products
to the farmers directly.

                                    MARKETING

     All three of our product lines are sold directly to the farming community
in rural areas or wholesalers through our distribution network. This consists of
12 established branches each representing 5 sales teams responsible for an
assigned territory.

     Since our inception, the "Bodisen" brand has been aggressively marketed and
promoted, through trade fairs, conventions and the print media. We also promote
our product lines through television and radio adverting in China. Since the
end-user for our products is the local farmer, we utilize educational seminars
to promote products directly to farmers. These educational seminars are
conducted locally in China and explain the advantages of organic fertilizers and
how they may be used to enhance crop yields. We market directly to farmers,
which allows us to collect feedback to help in preparing and designing products
based on the needs of the farmers. Included in this process is the distribution
of free samples that attract attention and increase brand awareness.

     The free samples are made available to allow farmers the opportunity to
test the product and compare it to other fertilizer products. After the farmers
participate in this test, we announce and promote the results to surrounding
towns in the test zone. The cost of this is not material and is often offset by
new sales in that test zone. The objective of this test is to compare our
products with the similar products of competitors.


     The primary task for sales and marketing is to strengthen the home market
in Shaanxi province and expand the market outside Shaanxi province into new
districts where our products are not well established. We will try to accomplish
this through traditional means, which are to use the market strategies of price
control and the establishment of franchising its distribution to wholesalers.


     We intend to increase marketing in regions where our products are not well
known. In addition, we will promote our products through national newspapers in
China explaining the advantages of the high-tech nature of its environmental or
"green" product lines. In order to enter the untapped markets of western China,
we will explore selling exclusive franchise opportunities to new wholesale
agents.


               SOURCES AND AVAILABILITY OF RAW MATERIALS (VENDORS)


     There are numerous suppliers and vendors of raw materials in the Shaanxi
Province of China from which we can choose from in satisfying our production
requirements. We have no contracts with trade vendors and conduct business on an
order-by-order basis, a practice that is typical throughout the industry in
China. We believe that we have very good relations with the agricultural vendor
community.


                                    CUSTOMERS


     All orders for our products are informal and are indications of interest
which can be canceled by the customers at anytime and for any reason. In China,
orders of indication are the norm, and are based on the goodwill of a company's
relationships with its customers. All orders that we sign with customers are
informal indications of interest and there are no written or verbal sales
contracts with its customers. Signed orders on file with us will be filled on a
first come-first served basis, as the product is manufactured and distributed.


                                       3
<PAGE>
                              INTELLECTUAL PROPERTY

     We own a trademark on the "BODISEN" name, which is used on all our
products. BODISEN is also a recognized trade name in the provinces in China in
which we conduct business.


     We hold no patents and have not applied for patents on our proprietary
technology or formulas because we believe application for such patents in China
would result in public knowledge of our proprietary technology and formulas,
which would be detrimental to our future well-being. Only certain key executives
of ours have knowledge of such proprietary technology and formulas.


                            RESEARCH AND DEVELOPMENT


     Our research and development team consists of nine professionals, which
perform administrative and ministerial functions. Much of our research work is
done in close cooperation with universities and research labs in the Yang Ling
and Xian metropolitan areas and the cost of such research work is incurred by
such universities and research labs and not by us.

     In 2004, we plan to spend $130,000.00 on research and development, a
majority of which is dedicated to current experiments to develop new products.

Current Research and Development Projects

     Project Ion: The study of metal ions, copper, zinc and maganese in
combination with silver positive ion to control and remove crop disease brought
about by fungus. We are trying to determine if the combination of these metal
ions will prohibit the release of an intrusive enzyme from fungus that kills
crops in China.

     Project Fly: The development of a protein abstract from a common fly to
develop bacteria-based pesticides, which may have better effect on plant's
resistance to insects. This project seeks to isolate a series of anti-bacteria
peptides from the proteins of a common fly. This kind of anti-bacteria peptide
could effectively control many pathogens which may prove better than pesticides
currently available.

     Project Amino Acid: Program to build a new compound fertilizer product,
based on a proactive amino acid enzyme.

     Project Build: A technique for the manufacturing of organic compound
fertilizer, which could enhance the quality of organic fertilizer products.

                    GOVERNMENTAL AND ENVIRONMENTAL REGULATION

     Through the laws and regulation of the People's Republic of China and
Shaannxi Provincial government, our products and services are subject to
material regulation by governmental agencies responsible for the Agricultural
Industry and through the government district where we are headquartered.
Business and company registrations, along with our products, are certified on a
regular basis and must be in compliance with the laws and regulations of the
state governments and industry agencies, which are controlled and monitored
through the issuance of licenses. To date, we have been compliant with all
registrations and requirements for the issuance and maintenance of all licenses
required by the governing bodies. As of March 15, 2004, all license fees and
filings are current. These licenses include:

     o    PRODUCTION OF ORGANIC COMPOUND FERTILIZER LICENSE. Authorized by the
          Shaanxi Soil and Fertilizer Institution. After June 2004, this
          production license will be transferred to a Production License
          authorized by Ministry of Agriculture, People's Republic of China.

     o    CERTIFICATE FOR PESTICIDE REGISTRATION. Is required for the production
          of liquid fertilizer and issued by Ministry of Agriculture, People's
          Republic of China.

     o    PRODUCTION STANDARD. Registered with Bureau of Quality Controls and
          Technology, Shaanxi Provincial Government, Xi'an.


                                       4
<PAGE>
     There is no prohibitive cost in obtaining and maintaining these licenses,
and it is illegal to do business without these licenses. As it is an accepted
business practice to operate within the regulations of the issued license, the
issuance of the license is considered a cost of doing business and fees
associated with this are minimal. If we were to lose any of these licenses, we
would only have a limited time to reapply for such licenses and would face
possible regulatory fines. We are not subject to any environmental controls or
restrictions that require the outlay of capital or the obtaining of a permit in
order to engage in business operations.

                                   COMPETITION

     The compound fertilizer industry is largely fragmented with most
competitors operating small regional factories, serving local requirements. Most
companies in this industry in China do not promote their products through brand
name recognition.

     We have not yet identified any competition in Shaanxi province that
operates in all three segments (compound, liquid and pesticide) of the organic
fertilizer business. Our nearest competitor is Tian Bang Shaanxi. We believe
that the only international company operating in China which is a competitor to
us is DuPont. We compete and sell our products in seventeen provinces throughout
China including Shaanxi, Hebei, Shandong, Liaoning, Jilin, Heilongjiang, Gansu,
Sichuan, Henan, Shanxi, Guangxi, Xinjiang, Inner Mongolia, Ningxia, Qinghai,
Yunnan and Hainan.

Employees

     As of March 15, 2004, we employed a total of 349 employees, 251 on a
full-time basis, 26 of which are clerical, 74 of which are in operations, 5 in
accounting, 128 of which are sales and marketing, 9 of which are administrative
and 9 of which are research and development. We also employ 98 part-time
employees who are farmers.

ITEM 2. DESCRIPTION OF PROPERTY.

     Our principal executive offices are located at North Part of Xinquia Road,
Yang Ling Agricultural High-Tech Industries Demonstration Zone Yang Ling,
Shaanzi province, People's Republic of China, 712100 and our telephone number is
011-86-29-87074957. We own two factories, which include three production lines,
an office building, one warehouse, and two research labs which are located on
10,900 square meters of land. We also lease a warehouse in Yang Ling near the
site of our factories. This warehouse is 300 square meters in area. The rent of
the warehouse is $1,500.00 a month from May 20, 2003 to May 20, 2004. We believe
that our owned and leased property is sufficient for our current and immediately
foreseeable operating needs.

ITEM 3. LEGAL PROCEEDINGS.

     From time to time, we may become involved in various lawsuits and legal
proceedings which arise in the ordinary course of business. However, litigation
is subject to inherent uncertainties, and an adverse result in these or other
matters may arise from time to time that may harm our business. We are currently
not aware of any such legal proceedings or claims that we believe will have,
individually or in the aggregate, a material adverse affect on our business,
financial condition or operating results.


ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

         None.

                                       5
<PAGE>
                                     PART II

ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS.

                            MARKET FOR COMMON EQUITY

     Our common stock trades on the NASD Over-The-Counter Bulletin Board under
the symbol "BBOI." The Over-The-Counter Bulletin Board is sponsored by the
National Association of Securities Dealers (NASD) and is a network of security
dealers who buy and sell stocks.

     For the periods indicated, the following table sets forth the high and low
bid prices per share of common stock. These prices represent inter-dealer
quotations without retail markup, markdown, or commission and may not
necessarily represent actual transactions.

                                    Low($)    High($)
                                    ------    ------
2003
Fourth Quarter (1)                  0.25      0.90

2004
First Quarter (2) (3)               0.25     13.90

(1) Our stock first started trading on December 1, 2003
(2) As of March 25, 2004
(3) We effected a 4:1 forward split on March 3, 2004.

     As of March 22, 2004, management believes there to be approximately 42
holders of record of our common stock. To date, we have not paid any dividends
on our common stock. We do not currently intend to pay dividends in the future.

                     RECENT SALES OF UNREGISTERED SECURITIES

None.

PRIVATE PLACEMENTS OF COMMON STOCK AND WARRANTS FOR CASH

None.

SALES OF DEBT FOR CASH

None.

OPTION GRANTS

None.

ISSUANCES OF STOCK FOR SERVICES OR IN SATISFACTION OF OBLIGATIONS

None.


                                       6
<PAGE>
ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

     Some of the information in this Form 10-KSB contains forward-looking
statements that involve substantial risks and uncertainties. You can identify
these statements by forward-looking words such as "may," "will," "expect,"
"anticipate," "believe," "estimate" and "continue," or similar words. You should
read statements that contain these words carefully because they:

     o    discuss our future expectations;

     o    contain projections of our future results of operations or of our
          financial condition; and

     o    state other "forward-looking" information.

     We believe it is important to communicate our expectations. However, there
may be events in the future that we are not able to accurately predict or over
which we have no control. Our actual results and the timing of certain events
could differ materially from those anticipated in these forward-looking
statements as a result of certain factors, including those set forth under "Risk
Factors," "Business" and elsewhere in this annual report. See "Risk Factors."

Operating Results for the Years Ended December 31, 2003 and 2002

     Operating expenses increased from $91,491 in fiscal year 2002 to $107,592
in fiscal year 2003. This increase represented our continued development and
implementation of our business during fiscal year 2003. Professional and
consulting fees aggregated $70,346 which included $37,652 of professional fees
relating to the preparation of our reports in compliance with the Securities
Exchange Act. Consulting fees also include $32,694 earned by the Company's
President in lieu of salary. Operating expenses include donated services valued
at $8,000 for fiscal year 2003 and $2,000 for fiscal year 2002 relating to the
development of the Company's business plan by its President. The Company paid
$7,522 in office rent and telephone costs and received $4,000 of donated rent
from its President. The Company spent $9,021 in travel and promotion as the
Company sought to increase the awareness and use of its web based mortgage
business.

     The Company's net loss for the year 2003 was $49,336 compared to a net loss
of $78,660 in fiscal year 2002. The decreased loss recorded in 2003, reflects
the substantial increase in revenues during fiscal year 2003.

Liquidity and Capital Resources

        The following discussion of liquidity and capital resources relates to
Bodisen International, Inc., the company we acquired in February, 2004. We have
included the discussion of liquidity and capital resources for Bodisen as we
believe it is important to have a prospective look going forward for this
section, and as a result of the acquisition, our business has become that of
Bodisen.

         As of December 31, 2003, Bodisen International had $2,974,773 cash on
hand, compared to $233,182 cash on hand as of December 31, 2002, as a result of
cash provided from operations. We believe that our current cash needs for at
least the next twelve months can be met from working capital. As of December 31,
2003, Bodisen International decreased inventory by $81,538 and Bodisen
International's plant and equipment by $4,903. Accounts payable increased by
$535,185 to $1,634,163. Short term loans increased to $1,092,000 from $12,000.
We do not currently have any contracts, plans or agreements in place for any
additional financing. There can be no assurance that financing will be available
in amounts or on terms acceptable to us, if at all. During the 2003 fiscal year,
Bodisen International's accounts receivable decreased from $2,071,927 to
$1,822,841. We are not aware of any material trend, event or capital commitment
which would potentially adversely affect liquidity.

         The majority of Bodisen International's revenues and majority of the
expenses in 2003 were denominated primarily in Renminbi ("RMB"), the currency of
the People's Republic of China. There is no assurance that exchange rates
between the RMB and the U.S. dollar will remain stable. A devaluation of the RMB
relative to the U.S. dollar could adversely affect our business, financial
condition and results of operations. We do not engage in currency hedging.
Inflation has not had a material impact on our business.


                                       7
<PAGE>
ITEM 7. FINANCIAL STATEMENTS.

Stratabid.com, Inc.
(A Development Stage Company)
<TABLE>
<CAPTION>

                                                                                                              Index

<S>                                                                                                               <C>
Independent Auditor's Report....................................................................................F-2

Consolidated Balance Sheets.....................................................................................F-3

Consolidated Statements of Operations...........................................................................F-4

Consolidated Statements of Cash Flows...........................................................................F-5

Consolidated Statement of Stockholders' Equity..................................................................F-6

Notes to the Consolidated Financial Statements..................................................................F-7

Consolidated Pro Forma Statement of Operations..................................................................F-12

Consolidated Pro Forma Statement of Financial Conditions .......................................................F-13

</TABLE>

<PAGE>
                          Independent Auditor's Report


To the Board of Directors and Stockholders of
Stratabid.com, Inc.
(A Development Stage Company)


We have audited the accompanying  consolidated  balance sheets of Stratabid.com,
Inc. (A  Development  Stage  Company)  as of December  31, 2003 and 2002 and the
related  consolidated  statements of  operations,  cash flows and  stockholders'
equity  accumulated  for the period from January 14, 2000 (Date of Inception) to
December  31,  2003 and the  years  ended  December  31,  2003 and  2002.  These
financial  statements are the  responsibility of the Company's  management.  Our
responsibility  is to express an opinion on these financial  statements based on
our audits.

We conducted our audits in accordance with auditing standards generally accepted
in the United States. Those standards require that we plan and perform the audit
to obtain reasonable  assurance about whether the financial  statements are free
of material misstatement. An audit includes examining, on a test basis, evidence
supporting  the amounts and  disclosures in the financial  statements.  An audit
also includes assessing the accounting principles used and significant estimates
made by  management,  as well as  evaluating  the  overall  financial  statement
presentation.  We believe  that our audits  provide a  reasonable  basis for our
opinion.

In our opinion,  the aforementioned  consolidated  financial  statements present
fairly, in all material respects, the financial position of Stratabid.com,  Inc.
(A Development Stage Company), as of December 31, 2003 and 2002, and the results
of its operations and its cash flows accumulated for the period from January 14,
2000 (Date of Inception)  to December 31, 2003 and the years ended  December 31,
2003 and 2002, in conformity with accounting  principles  generally  accepted in
the United States.

The accompanying  financial  statements have been prepared  assuming the Company
will  continue  as a going  concern.  As  discussed  in Note 1 to the  financial
statements,  the Company has not obtained profitable  operations since inception
and will need equity  financing to begin realizing upon its business plan. These
factors raise  substantial  doubt about the  Company's  ability to continue as a
going concern.  Management's plans in regard to these matters are also discussed
in Note 1. The financial  statements do not include any  adjustments  that might
result from the outcome of this uncertainty.

/s/Manning Elliot
-----------------
   Manning Elliot

CHARTERED ACCOUNTANTS

Vancouver, Canada

February 10, 2004

                                      F-2
<PAGE>
Stratabid.com, Inc.
(A Development Stage Company)
Consolidated Balance Sheets
(Expressed in U.S. dollars)
<TABLE>
<CAPTION>
                                                  December 31,         December 31,
                                                      2003                 2002
                                                        $                   $
Assets
Current Assets
<S>                                                                         <C>
  Cash                                                       -                3,761
  Accounts receivable                                      357                4,012
  Loan receivable (Note 4)                              14,270                    -
------------------------------------------------  -------------        -------------
Total Current Assets                                    14,627                7,773

Equipment (Note 3)                                       4,058                1,644
Website Development Costs (Note 3)                       1,375                1,696
Deferred Financing Cost (Note 5)                             -               19,345
------------------------------------------------  -------------        -------------
Total Assets                                            20,060               30,458
------------------------------------------------  -------------        -------------

Liabilities and Stockholders' Equity (Deficit)

Current Liabilities

   Accounts payable (Note 6(d))                         10,427               33,610
   Accrued liabilities                                   9,392                5,500
   Due to a related party (Note 6(c))                    1,231                4,873
------------------------------------------------  -------------        -------------

Total Liabilities                                       21,050               43,983
------------------------------------------------  -------------        -------------

Commitments (Note 1)

Stockholders' Deficit

Preferred Stock, 5,000,000 preferred shares
authorized with a par value of $0.0001, none issued          -                    -

Common Stock, 30,000,000 common shares
authorized with a par value of $0.0001,
1,567,000 and 1,254,000 common shares
issued and outstanding, respectively                       157                  125

Additional Paid in Capital                             113,211               64,375

Donated Capital (Note 6(a))                             30,000               18,000
------------------------------------------------  -------------        -------------
                                                       143,368               82,500
Accumulated Other Comprehensive Gain (Loss)                818                 (185)
Deficit Accumulated During the Development Stage      (145,176)             (95,840)
------------------------------------------------  -------------        -------------

Total Stockholders' Deficit                               (990)             (13,525)
------------------------------------------------  -------------        -------------

Total Liabilities and Stockholders' Deficit             20,060               30,458
================================================  =============        =============
</TABLE>
   (The accompanying notes are an integral part of the financial statements)

                                      F-3
<PAGE>
Stratabid.com, Inc.
(A Development Stage Company)
Consolidated Statements of Operations
(Expressed in U.S. dollars)
<TABLE>
<CAPTION>
                                                                                                            From
                                                                 Year                 Year            January 14, 2000
                                                                Ended                 Ended          (Date of Inception)
                                                             December 31,         December 31,         to December 31,
                                                                 2003                 2002                  2003
                                                                  $                     $                     $


<S>                                                               <C>                     <C>                 <C>
Revenue                                                           58,256                  12,831              71,087
-----------------------------------                           -----------             -----------          ----------
Expenses
Accounting and audit                                               8,980                   8,600              18,580
Amortization                                                       1,722                     239               1,961
Bank charges                                                         538                     407               1,186
Consulting (Note 6(b))                                            32,694                  39,338              72,032
Discount on shares issued                                              -                  12,700              12,700
Donated rent (Note 6(a))                                           4,000                   1,000               8,000
Donated services (Note 6(a))                                       8,000                   2,000              22,000
Foreign exchange loss (gain)                                        (142)                    623                 481
Interest income                                                     (357)                      -                (357)
Legal                                                             28,672                  13,332              42,153
Office, rent and telephone                                         7,522                   5,506              13,028
Organizational                                                         -                     521               1,311
Transfer agent and regulatory fees                                 6,942                   3,821              10,763
Travel and promotion                                               9,021                   3,404              12,425
-----------------------------------                           -----------             -----------          ----------
                                                                 107,592                  91,491             216,263
-----------------------------------                           -----------             -----------          ----------
Net Loss for the Year                                            (49,336)                (78,660)           (145,176)
===================================                           ===========             ===========          ==========
Net Loss Per Share                                                (0.03)                  (0.07)
===================================                           ===========             ===========          ==========
Weighted Average Shares Outstanding                            1,447,000               1,127,000
===================================                           ===========             ===========          ==========
</TABLE>
(Diluted loss per share has not been presented as the result is anti-dilutive)

(The accompanying notes are an integral part of the financial statements)

                                      F-4
<PAGE>
Stratabid.com, Inc.
(A Development Stage Company)
Consolidated Statements of Cash Flows
(Expressed in U.S. dollars)
<TABLE>
<CAPTION>
                                                                                                                    From
                                                                      Year                  Year               January 14, 2000
                                                                      Ended                 Ended            (Date of Inception)
                                                                  December 31,          December 31,           to December 31,
                                                                      2003                  2002                     2003
                                                                        $                     $                       $

<S>                                                              <C>                     <C>                         <C>
Cash Flows to Operating Activities

Net loss for the period                                                 (49,336)             (78,660)                (145,176)

Adjustments to reconcile net loss to cash

Amortization                                                              1,722                  239                    1,961
Discount on shares issued                                                     -               12,700                   12,700
Donated services and rent                                                12,000                3,000                   30,000
Organizational expenses paid by a shareholder                                 -                    -                      790

Change in non-cash working capital items

Decrease (increase) in accounts receivable                                3,655               (4,012)                    (357)
Increase (decrease) in accounts payable and accrued
   liabilities                                                          (19,291)              38,110                   19,819
----------------------------------------------------                 -----------            ---------                ---------
Net Cash Used by Operating Activities                                   (51,250)             (28,623)                 (80,263)
----------------------------------------------------                 -----------            ---------                ---------
Cash Flows to Investing Activities

Loan to an unrelated party                                              (14,270)                   -                  (14,270)
Purchase of equipment                                                    (3,448)              (1,883)                  (5,331)
Website development costs                                                     -               (1,696)                  (1,696)
----------------------------------------------------                 -----------            ---------                ---------
Net Cash Used In Investing Activities                                   (17,718)              (3,579)                 (21,297)
----------------------------------------------------                 -----------            ---------                ---------
Cash Flows from Financing Activities

Proceeds from a related party                                             1,231                4,623                    6,104
Repayment of loan from related party                                     (4,873)                   -                   (4,873)
Common stock issued, net of offering costs                               68,213               50,800                  119,223
Payment of deferred financing costs                                           -              (19,345)                 (19,345)
----------------------------------------------------                 -----------            ---------                ---------
Net Cash Provided by Financing Activities                                64,571               36,078                  101,109
----------------------------------------------------                 -----------            ---------                ---------
Effect of Exchange Rate Changes on Cash                                     636                 (185)                     451
----------------------------------------------------                 -----------            ---------                ---------
(Decrease) Increase in cash                                              (3,761)               3,691                        -
Cash - beginning of period                                                3,761                   70                        -
----------------------------------------------------                 -----------            ---------                ---------
Cash - end of period                                                          -                3,761                        -
----------------------------------------------------                 -----------            ---------                ---------

Non-Cash Financing Activities

Discount on shares issued                                                     -               12,700                   12,700
----------------------------------------------------                 -----------            ---------                ---------
Supplemental Disclosures

Interest paid                                                                 -                    -                        -
Income tax paid                                                               -                    -                        -
</TABLE>
   (The accompanying notes are an integral part of the financial statements)

                                      F-5
<PAGE>
Stratabid.com, Inc.
(A Development Stage Company)
Consolidated Statement of Stockholders' Equity
From January 14, 2000 (Date of Inception) to December 31, 2003
(Expressed in U.S. dollars)
<TABLE>
<CAPTION>
                                                                                                               Deficit
                                                                                             Accumulated     Accumulated
                                                                     Additional                 Other        During the
                                                                      Paid-in    Donated    Comprehensive   Development
                                                Shares      Amount    Capital    Capital         Loss           Stage       Total
                                                  #           $          $          $             $               $           $

<S>            <C>                             <C>            <C>          <C>                                                <C>
Balance - January 14, 2000 (Date of
Inception)                                             -           -           -             -          -             -           -

Stock issued for cash and organizational
expenses (Note 3)                              1,000,000         100         900             -          -             -       1,000

Net loss for the period                                -           -           -             -          -          (954)       (954)
--------------------------------------------  ----------- -----------  ----------  ------------  ---------  ------------  ----------
Balance - December 31, 2000                    1,000,000         100         900             -          -          (954)         46

Value of services and rent donated by a
related party                                          -           -           -        15,000          -             -      15,000

Net loss for the year                                  -           -           -             -          -       (16,226)    (16,226)
--------------------------------------------  ----------- -----------  ----------  ------------  ---------  ------------  ----------
Balance - December 31, 2001                    1,000,000         100         900        15,000          -       (17,180)     (1,180)

Stock issued at $0.25 per share less a $0.05
per share discount for cash proceeds of
$0.20 per share                                  254,000          25      63,475             -          -             -      63,500

Translation adjustment                                 -           -           -             -       (185)            -        (185)

Value of services and rent donated by a
related party                                          -           -           -         3,000          -             -       3,000

Net loss for the year                                  -           -           -             -          -       (78,660)    (78,660)
--------------------------------------------  ----------- -----------  ----------  ------------  ---------  ------------  ----------
Balance - December 31, 2002                    1,254,000         125      64,375        18,000       (185)      (95,840)    (13,525)


Stock issued at $0.25 per share net of
offering costs                                   313,000          32      48,836             -          -             -      48,868

Translation adjustment                                 -           -           -             -      1,003             -       1,003

Value of services and rent donated by a
related party                                          -           -           -        12,000          -             -      12,000

Net loss for the year                                  -           -           -             -          -       (49,336)    (49,336)
--------------------------------------------  ----------- -----------  ----------  ------------  ---------  ------------  ----------
Balance - December 31, 2003                    1,567,000         157     113,211        30,000        818      (145,176)       (990)
============================================  =========== ===========  ==========  ============  =========  ============  ==========
</TABLE>
  (The accompanying notes are an integral part of the financial statements)

                                      F-6
<PAGE>
Stratabid.com, Inc.
(A Development Stage Company)
Notes to the Consolidated Financial Statements
For the Period From January 14, 2000 (Date of Inception) to December 31, 2003
(Expressed in U.S. dollars)

1.   Development Stage Company

     Stratabid.com, Inc. herein (the "Company") was incorporated in the State of
     Delaware,  U.S.A.  on January 14,  2000.  The  Company is a start-up  stage
     Internet based commercial mortgage origination business based in Vancouver,
     BC,  Canada.  The  Company  offers  an  online  alternative  for  arranging
     commercial term  mortgages.  The Company gives borrowers the opportunity to
     apply  directly to a qualified  market of lenders  interested  in financing
     their asset.  Borrowers will be able to log on to a website where they will
     find a home page featuring  lenders logos and links to three separate areas
     to work on their  financing  needs.  In one area  they  will  find a set of
     software  tools to do technical  analysis such as compare  interest  rates,
     loan payments,  amortizations,  financing  scenario  comparisons and payout
     calculations.  Another area will be a showcase of the lending  partners and
     their  products.  In the  last  area  borrowers  will  complete  an  online
     application form and return it to the website.  An experienced  underwriter
     for the  Company  will  review and  forward it to the  lending  partners to
     provide  quotes on the deal. The lender that is successful in arranging the
     financing will pay the Company a referral fee for the business. For lending
     partners the Company provides two benefits.  Firstly it provides a targeted
     forum  to  promote  their   products  and  build  their  brand,   which  is
     increasingly  important in today's  constantly  changing  mortgage  market.
     Secondly it generates financing  opportunities at no cost. The lenders only
     pay referral fees when successful in arranging a loan.

     The  Company is in the early  development  stage.  In a  development  stage
     company,  management  devotes most of its activities in developing a market
     for its  products and  services.  The ability of the Company to emerge from
     the  development  stage with  respect  to any  planned  principal  business
     activity  is  dependent  upon its  successful  efforts to raise  additional
     equity financing and/or attain profitable operations. There is no guarantee
     that the Company will be able to raise any equity  financing or sell any of
     its products and services at a profit. There is substantial doubt regarding
     the Company's ability to continue as a going concern.

     In January 2003, the Company filed a SB-2  Registration  Statement with the
     United States  Securities and Exchange  Commission (SEC) which was declared
     effective on January 24, 2003.  Pursuant to the Registration
Statement the
     Company  issued  313,000  common shares at $0.25 each during the year ended
     December 31, 2003 for total proceeds of $78,250.  The Company paid $29,382,
     including  $19,345  in  deferred  financing  costs in the prior  year,  for
     professional   fees  relating  to  the  preparation  of  the   Registration
     Statement.

     In January  2004,  the  President  of the Company  advanced  $24,250 to the
     Company  for  working   capital   purposes.   This  amount  is   unsecured,
     non-interest  bearing and due on demand.  The  Company  will  continue  its
     mortgage  brokerage  activities  to generate  revenues  and will also raise
     additional  working  capital,  if  necessary,  through  the sale of  equity
     securities or the issuance of debt instruments.  Operating expenses for the
     next twelve months are expected to remain  relatively  consistent  with the
     current year.

2.   Summary of Significant Accounting Policies

     (a)  Use of Estimates

     The preparation of financial  statements in conformity with U.S.  generally
     accepted  accounting  principles  requires management to make estimates and
     assumptions  that affect the reported amounts of assets and liabilities and
     disclosure  of  contingent  assets  and  liabilities  at  the  date  of the
     financial  statements  and the  reported  amounts of revenues  and expenses
     during the periods. Actual results could differ from those estimates.

     (b) Consolidated Financial Statements

     These financial statements include the accounts of Stratabid.com,  Inc. and
     its wholly-owned  Canadian subsidiary  Stratabid.com Online (B.C.) Ltd. All
     inter-company balances have been eliminated.

     (c) Year End

     The Company's fiscal year end is December 31.

                                      F-7
<PAGE>
2.   Summary of Significant Accounting Policies (continued)

     (d) Cash and Cash Equivalents

     The Company  considers  all highly  liquid  instruments  with a maturity of
     three months or less at the time of issuance to be cash equivalents.

     (e) Equipment

     Equipment is stated at cost.  Amortization  is computed on a 30%  declining
     balance basis.

     (f)  Website Development Costs

     The Company  recognizes the costs  associated  with developing a website in
     accordance  with the American  Institute of  Certified  Public  Accountants
     ("AICPA") Statement of Position ("SOP") No. 98-1, "Accounting for the Costs
     of Computer Software  Developed or Obtained for Internal Use".  Relating to
     website  development costs the Company follows the guidance pursuant to the
     Emerging  Issues  Task  Force  (EITF) No.  00-2,  "Accounting  for  Website
     Development Costs".

     The Company's  website is currently being developed.  Costs associated with
     the website  will  consist  primarily  of software  purchased  from a third
     party. The Company is capitalizing  costs of computer software obtained for
     internal use in web design and network operations.  These capitalized costs
     will be amortized  based on their  estimated  useful life over three years.
     Payroll  and  related  costs  will  not  be  capitalized,  as  the  amounts
     principally   relate  to   maintenance.   Internal  costs  related  to  the
     development of website content will be expensed as incurred.

     (g) Long-Lived Assets

     In accordance with Financial  Accounting Standards Board ("FASB") Statement
     of Financial  Accounting  Standards  ("SFAS") No. 144,  Accounting  for the
     Impairment  or  Disposal  of Long  Lived  Assets",  the  carrying  value of
     intangible  assets and other  long-lived  assets is  reviewed  on a regular
     basis  for the  existence  of  facts  or  circumstances  that  may  suggest
     impairment.  The  Company  recognizes  an  impairment  when  the sum of the
     expected undiscounted future cash flows is less than the carrying amount of
     the asset.  Impairment  losses,  if any,  are measured as the excess of the
     carrying amount of the asset over its estimated fair value.

     (h) Foreign Currency Translation

     The  functional  currency  of  the  Company's  Canadian  subsidiary  is the
     Canadian dollar. The financial statements of this subsidiary are translated
     to United States dollars in accordance  with SFAS No. 52 "Foreign  Currency
     Translation" using period-end rates of exchange for assets and liabilities,
     and  average  rates of exchange  for the year for  revenues  and  expenses.
     Translation gains (losses) are recorded in accumulated other  comprehensive
     income  (loss) as a component of  stockholders'  equity.  Foreign  currency
     transaction gains and losses are included in current operations.

     (i)  Revenue Recognition

     The  Company  receives  from  lenders a  referral  fee when the  Company is
     successful  in arranging a loan.  The referral fee revenue is recognized in
     the period the fee is earned.  The Company recognizes revenue in accordance
     with Securities and Exchange  Commission Staff Accounting  Bulletin No. 101
     ("SAB 101"),  "Revenue  Recognition  in Financial  Statements."  Revenue is
     recognized  only  when  the  price is  fixed  or  determinable,  persuasive
     evidence  of  an  arrangement   exists,  the  service  is  performed,   and
     collectibility is reasonably assured.

                                      F-8
<PAGE>
2.   Summary of Significant Accounting Policies (continued)

     (j)  Basic and Diluted Net Income (Loss) Per Share

          The Company  computes net income (loss) per share in  accordance  with
          SFAS No.  128,  "Earnings  per Share"  (SFAS 128).  SFAS 128  requires
          presentation of both basic and diluted earnings per share (EPS) on the
          face of the income  statement.  Basic EPS is computed by dividing  net
          income  (loss)  available to common  shareholders  (numerator)  by the
          weighted average number of shares outstanding (denominator) during the
          period.  Diluted EPS gives  effect to all  dilutive  potential  common
          shares  outstanding  during the period including stock options,  using
          the treasury stock method, and convertible  preferred stock, using the
          if-converted method. In computing Diluted EPS, the average stock price
          for the period is used in determining  the number of shares assumed to
          be purchased  from the exercise of stock options or warrants.  Diluted
          EPS  excludes all  dilutive  potential  shares if their effect is anti
          dilutive.

     (k)  Financial Instruments

          The fair values of cash and  equivalents,  loan  receivable,  accounts
          payable and accrued  liabilities  were estimated to approximate  their
          carrying  values due to the immediate or short-term  maturity of these
          financial  instruments.  The  Company's  operations  are in Canada and
          virtually  all of its  assets  and  liabilities  are  giving  rise  to
          significant  exposure to market risks from changes in foreign currency
          rates. The financial risk is the risk to the Company's operations that
          arise from  fluctuations  in foreign  exchange rates and the degree of
          volatility  of  these  rates.  Currently,  the  Company  does  not use
          derivative  instruments  to reduce its  exposure  to foreign  currency
          risk.

     (l)  Other Comprehensive Loss

          SFAS No. 130, "Reporting  Comprehensive Income," establishes standards
          for the reporting and display of comprehensive loss and its components
          in the financial  statements.  The Company had a comprehensive loss of
          $50,379 and $78,845 which includes a foreign currency translation gain
          of  $1,003  and a loss  of  $185,  at  December  31,  2003  and  2002,
          respectively.

     (m)  Recent Accounting Pronouncements

          In May 2003,  the FASB issued SFAS No.  150,  "Accounting  for Certain
          Financial  Instruments  with  Characteristics  of both Liabilities and
          Equity".  SFAS  No.  150  establishes  standards  for  how  an  issuer
          classifies   and   measures   certain   financial   instruments   with
          characteristics  of both  liabilities and equity.  It requires that an
          issuer  classify a financial  instrument that is within its scope as a
          liability (or an asset in some  circumstances).  The  requirements  of
          SFAS No.  150 apply to  issuers'  classification  and  measurement  of
          freestanding financial instruments, including those that comprise more
          than one  option or forward  contract.  SFAS No. 150 does not apply to
          features  that are  embedded in a financial  instrument  that is not a
          derivative  in its  entirety.  SFAS No. 150 is effective for financial
          instruments entered into or modified after May 31, 2003, and otherwise
          is effective at the  beginning of the first interim  period  beginning
          after  June  15,  2003,  except  for  mandatory  redeemable  financial
          instruments  of  non-public  entities.  It  is to  be  implemented  by
          reporting the cumulative effect of a change in an accounting principle
          for financial instruments created before the issuance date of SFAS No.
          150 and still  existing  at the  beginning  of the  interim  period of
          adoption.  Restatement is not permitted. The adoption of this standard
          did not have a material effect on the Company's  results of operations
          or financial position.

                                      F-9
<PAGE>
2.   Summary of Significant Accounting Policies (continued)

     (m)  Recent Accounting Pronouncements (continued)

          In June,  2002,  FASB  issued  SFAS No.  146,  "Accounting  for  Costs
          Associated with Exit or Disposal  Activities".  The provisions of this
          Statement  are  effective  for exit or  disposal  activities  that are
          initiated after December 31, 2002, with early application  encouraged.
          This Statement addresses financial  accounting and reporting for costs
          associated  with exit or disposal  activities  and nullifies  Emerging
          Issues Task Force (EITF) Issue No. 94-3,  "Liability  Recognition  for
          Certain  Employee  Termination  Benefits  and  Other  Costs to Exit an
          Activity (including Certain Costs Incurred in a Restructuring)".  This
          Statement requires that a liability for a cost associated with an exit
          or disposal activity be recognized when the liability is incurred. The
          Company  adopted  SFAS No. 146 on January 1, 2003 which did not have a
          material  effect on the Company's  results of operations and financial
          position.

          FASB has also  issued  SFAS No. 145 and 147 but they will not have any
          relationship to the operations of the Company  therefore a description
          of each and their respective  impact on the Company's  operations have
          not been disclosed.


3.   Equipment and Website Development Costs
<TABLE>
<CAPTION>
                                                                                      December 31, 2003    December 31, 2002
                                                                  Accumulated           Carrying             Carrying
                                                     Cost        Amortization            Value                Value
                                                      $                $                   $                    $

<S>                                                 <C>              <C>                 <C>                  <C>
     Computer and presentation equipment            5,331            1,273               4,058                1,644
     Website development costs                      2,063              688               1,375                1,696
     -------------------------------------------- -----------  ------------------  ------------------- - -----------------
                                                    7,394            1,961               5,433                3,340
     -------------------------------------------- -----------  ------------------  ------------------- - -----------------

</TABLE>
4.   Loan Receivable

     The  Company   advanced   CAD$20,000  to  an  unrelated  party  during  the
     three-month  period ended September 30, 2003. The loan was made pursuant to
     a Director's  Resolution in the best interest of the Company and has a term
     of three months bearing simple interest at 10% per annum.  The loan was not
     repaid and therefore in default as of December 31, 2003.

5.   Common Shares

     The Company  issued 313,000 common shares at a price of $0.25 per share for
     total  proceeds  of $78,250  during the  current  year  pursuant to an SB-2
     Registration  Statement.  The Company paid  $29,382,  including  $19,345 in
     deferred  financing costs in the prior year, for professional fees relating
     to the preparation of the Registration Statement. The Company has accounted
     for these professional fees as offering costs in the current year.


6.   Related Party Transactions/Balances

     (a)  The  President  and sole  shareholder  developed the business plan the
          Company  is  exploiting  on behalf of the  Company  during  the fiscal
          period ended December 31, 2001.  The value for these services  charged
          to operations,  was $8,000 for the year ended December 31, 2003 (2002:
          $2,000).  Rent and  office  costs  valued at $4,000 for the year ended
          December 31, 2003 (2002:  $1,000) were paid for by this related  party
          and charged to operations. These services and costs, valued at $30,000
          from date of inception,  are treated as donated capital and charged to
          operations.

     (b)  The President of the Company was paid $32,694 for consulting  services
          during the year ended December 31, 2003 (2002: $24,876).

                                      F-10
<PAGE>
6.   Related Party Transactions/Balances (continued)

     (c)  A loan of $4,873 due to the President of the Company was repaid during
          the current year. The loan was unsecured, non-interest bearing and due
          on demand. During November 2003, the President of the Company advanced
          $1,231 to the Company which is unsecured, non-interest bearing and due
          on demand.

     (d)  Included in accounts  payable are amounts  owing to the  President  of
          $3,662 and $1,565  relating to expenses  paid on behalf of the Company
          for  the  years  ended  December  31,  2003  and  2002   respectively.
          Consulting services of $5,152 ($9,000 CDN) owing to the President were
          included in accounts payable for the year end December 31, 2002.

7.   Income Tax

     Potential  benefits of income tax losses are not recognized in the accounts
     until  realization  is more  likely  than  not.  The  Company  has  adopted
     Statement of Financial  Accounting Standards No. 109 ("SFAS 109") as of its
     inception.  The Company has incurred net operating  losses of approximately
     $102,000,  which expire starting in 2015.  Pursuant to SFAS 109 the Company
     is required to compute tax asset benefits for net operating  losses carried
     forward. Potential benefit of net operating losses have not been recognized
     in these financial  statements  because the Company cannot be assured it is

     more  likely  than not it will  utilize the net  operating  losses  carried
     forward in future years.

     The components of the net deferred tax asset at December 31, 2003 and 2002,
     and the statutory tax rate,  the effective tax rate and the elected  amount
     of the valuation allowance are scheduled below:

                                              2003              2002
                                               $                 $

Net Operating Loss                           45,086            82,054
Statutory Tax Rate                            34%               34%
Effective Tax Rate                             -                 -
Deferred Tax Asset                           15,329            27,898
Valuation Allowance                         (15,329)          (27,898)
-------------------------------------   ----------------- -----------------
Net Deferred Tax Asset                         -                 -
-------------------------------------   ----------------- -----------------

                                      F-11
<PAGE>
                               STRATABID.COM, INC.
                        PRO FORMA STATEMENT OF OPERATIONS
                      FOR THE YEAR ENDED DECEMBER 31, 2003
                                   (Unaudited)

The following Unaudited Pro Forma Statement of operations has been derived from
the audited financial statements of Stratabid.com, Inc., a Delaware Corporation
(A) for the year ended December 31, 2003 and the audited financial statements of
Bodisen International, Inc., a Delaware Corporation (B) for the year ended
December 31, 2003. The Pro Forma Statements of Operations reflects the
acquisition of B by a wholly-owned subsidiary of the Company A (a reporting
company) on February 24, 2004 in a acquisition using reverse acquisition method
of accounting and assumes that such acquisition was consummated as of January 1,
2003.

The Pro Forma Statement of Operations and financial conditions should be read in
conjunction with the Financial Statements of A, the Financial Statements of B
and the Notes to the financial statements. The Pro Forma Statements do not
purport to represent what the Company's results of operations and financial
conditions would actually have been if the acquisition of A had occurred on the
d accompanying data, are based on available information and the assumption set
forth in the foot notes below, which management believes are reasonable.
<TABLE>
<CAPTION>

                                                                      A              B            Pro Forma          Pro Forma
                                                                (Historical)    (Historical)      Adjustment         Combined
                                                                --------------  -------------   ---------------   ----------------

<S>                                                             <C>             <C>             <C>                     <C>
Net Revenue                                                     $      58,256   $  9,783,784    $           -           9,842,040

Cost of revenue                                                             -      6,706,082                -           6,706,082
                                                                --------------  -------------   ---------------   ----------------

Gross profit                                                           58,256      3,077,702                -           3,135,958

Operating expenses                                                    107,592      1,204,208                -           1,311,800
                                                                --------------  -------------   ---------------   ----------------

Loss from operations                                                  (49,336)     1,873,494                -           1,824,158

Non-operating income (Expenses)                                             -         96,867                -              96,867
                                                                --------------  -------------   ---------------   ----------------

Net gain/loss                                                   $     (49,336)  $  1,970,361    $           -           1,921,025
                                                                ==============  =============   ===============   ================

EARNINGS PER SHARE

   Weighted -average number of
   shares outstanding                                               1,567,000      3,000,000                            4,567,000
                                                                ==============  =============                     ================

   Gain/loss per share                                          $       (0.03)  $       0.66                      $          0.42
                                                                ==============  =============                     ================
</TABLE>
NOTES:

(1)  Loss per share data shown above are applicable for both primary and fully
     diluted.

(2)  Weighted-average number of shares outstanding for the combined entity
     includes all shares issued before the acquisition as if outstanding as of
     January 1, 2003.

(3)  Weighted average number of shares outstanding for combined entity includes
     1,567,000 shares of A outstanding shares as of December 31, 2003 and
     3,000,000 shares of common stock issued to the shareholders of (B) pursuant
     to the stock acquisition and reorganization agreement.


                                      F-12
<PAGE>
                               STRATABID.COM, INC.
                   PRO FORMA STATEMENT OF FINANCIAL CONDITIONS
                     FOR THE PERIOD ENDED DECEMBER 31, 2003
                                   (Unaudited)

The following unaudited Pro Forma Statement of financial conditions has been
derived from the audited financial statements of Stratabid.com, Inc. (A) as of
December 31, 2002 and the audited financial statements of Bodisen International,
Inc. (B) as of December 31, 2003. The unaudited Pro Forma Statements of
financial conditions reflects the acquisition of B by a wholly-owned subsidiary
of A (a reporting company) in a merger using reverse acquisition method of
accounting.

<TABLE>
<CAPTION>
                                                     A              B                               Pro Forma         Pro Forma
                                               (Historical)    (Historical)      Investment        Adjustment         Combined
                                               --------------  -------------   ---------------   ----------------   --------------
                           ASSETS

<S>                                               <C>             <C>             <C>                <C>                   <C>
Current Assets                                 $      14,627   $  7,446,862    $         -        $         -           7,461,489

Property & equipment, net                              4,058      1,220,587              -                  -           1,224,645

Intangible assets, net                              1,375.00      2,310,148              -                  -           2,311,523

Capital work in progress                                   -        222,083              -                  -             222,083

Investment - acquisition of subsidiary                     -              -      4,500,000 (2)     (4,500,000)(4)               -

                                               --------------  -------------   ---------------   ----------------   --------------
TOTAL ASSETS                                   $      20,060   $ 11,199,680    $ 4,500,000        $(4,500,000)       $ 11,219,740
                                               ==============  =============   ===============   ================   ==============


LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)

Current liabilities                            $      21,050    $ 2,832,106     $           -      $         -          2,853,156

Stockholders' equity;

  Common stock                                           157              1               300 (2)             (1)(1)          457


  Additional paid in capital                         113,211      6,014,399         4,499,700 (2)   (4,644,357)(4)      5,982,953

  Statutory reserve                                        -        263,795                 -                -            263,795

  Donated Capital                                     30,000              -                 -                -             30,000

  Accumulated other comprehensive gain (loss)            818              -                 -             (818)(3)              -

  Retained earnings (deficit)                       (145,176)     2,089,379                 -          145,176 (3)      2,089,379


                                                 --------------  -------------   ---------------   ----------------   --------------

     Total stockholders' equity (deficit)               (990)     8,367,574         4,500,000       (4,500,000)         8,366,584
                                                 --------------  -------------   ---------------   ----------------   --------------

TOTAL LIABILITIES AND STOCKHOLDERS'
EQUITY (DEFICIT)                               $      20,060   $ 11,199,680     $   4,500,000      $(4,500,000)       $11,219,740
                                                 ==============  =============   ===============   ================   ==============
</TABLE>
NOTES;

(1) Elimination of Common stock of (B) before the acquisition

(2) Issuance of shares of common stock to shareholder of (B) valued at
$4,500,000

(3) Elimination of pre-acquisition retained earnings of (B)

(4) Elimination of investment in subsidiary on consolidation

                                      F-13
<PAGE>
ITEM 8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE.

On February 26, 2004, we dismissed Manning Elliott, Chartered Accountants
("Manning") as our principal independent accountant. On February 26, 2004, we
engaged Kabani & Company, Inc. as our principal independent accountant. The
action to engage Kabani & Company, Inc. was taken upon the unanimous approval of
our Board of Directors.

During the last two fiscal years ended December 31, 2002 and December 31, 2001
and through February 26, 2004, there were no disagreements between the Company
and Manning on any matter of accounting principles or practices, financial
statement disclosure or auditing scope or procedure which, if not resolved to
the satisfaction of Manning would have caused Manning to make reference to the
matter in its reports on our financial statements. During the last two most
recent fiscal years ended December 31, 2002 and December 31, 2001 and through
February 26, 2004, there were no reportable events as the term described in Item
304(a)(1)(iv) of Regulation S-B.

During the two most recent fiscal years and through February 26, 2004, we have
not consulted with Kabani & Company, Inc. regarding either:

1.    the application of accounting principles to any specified transaction,
either completed or proposed, or the type of audit opinion that might be
rendered on our financial statements, and neither a written report was provided
to us nor oral advice was provided that Kabani & Company, Inc. concluded was an
important factor considered by us in reaching a decision as to the accounting,
auditing or financial reporting issue; or

2.    any matter that was either subject of disagreement or event, as defined
in Item 304(a)(1)(iv)(A) of Regulation S-B and the related instruction to Item
304 of Regulation S-B, or a reportable event, as that term is explained in Item
304(a)(1)(iv)(A) of Regulation S-B.

We requested that Manning furnish us with a letter addressed to the Securities
and Exchange Commission stating whether it agrees with the above statements. A
copy of such letter, dated February 26, 2004, was filed as Exhibit 4 to the Form
8-K filed with the Securities and Exchange Commission on February 27, 2004.


ITEM 8A. CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures
------------------------------------------------

As of December 31, 2003, we carried out an evaluation of the effectiveness of
the design and operation of its disclosure controls and procedures pursuant to
Exchange Act Rule 13a-14. This evaluation was done under the supervision and
with the participation of our Principal Executive Officer and Principal
Financial Officer. Based upon that evaluation, they concluded that our
disclosure controls and procedures are effective in gathering, analyzing and
disclosing information needed to satisfy our disclosure obligations under the
Exchange Act.

Changes in internal controls
----------------------------

There were no significant changes in our internal controls or in other factors
that could significantly affect those controls since the most recent evaluation
of such controls.


                                        8
<PAGE>




                                    PART III

ITEM 9. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS; COMPLIANCE
WITH SECTION 16(A) OF THE EXCHANGE ACT.



NAME                       AGE              POSITION
----                       ---              --------

Qiong Wang                 40               Chief Executive Officer and Director

Dingxiang Yang             39               Chief Financial Officer

Yongning Zhang             28               Secretary

Directors serve until the next annual meeting and until their successors are
elected and qualified. Officers are appointed to serve for one year until the
meeting of the board of directors following the annual meeting of stockholders
and until their successors have been elected and qualified.

Qiong Wang. Ms. Wang has served as the Chief Executive Officer and a director
since February, 2004. Previously, Ms. Wang was the Chairman of the Board of
Directors of Yang Ling from September 2001 until February, 2004. From 1997 to
May 2001, Ms. Wang was the Chief Executive Officer and President of Shaanxi
Bodison Chemical Co., Ltd., which became Yang Ling. From May 1996 to December
1997, Ms. Wang was the President of Yang Ling Kang Yuan Chemical Company. Ms.
Wang graduated from North-West Agronomy College, with a Bachelor of Science
degree in 1986.

Dingxiang Yang. Mr. Yang is a Certified Public Accountant in China and has been
our Chief Financial Officer since February, 2004. From 1997 until 2003, Mr. Yang
was the Head of Accounting Department at ShaanXi Agricultural Corporation, a
government agricultural product distribution firm. Mr. Yang was the Head of
Accounting Department of Xi'An Electric Motor Institute from 1986 until 1997.
Mr. Yang received a Bachelor's degree in accounting from ShaanXi Second
Institute of Commerce in 1986.

Yongning Zhang. Mr. Zhang has been the secretary since February, 2004. Between
1999 and February, 2004, Mr. Zhang was the human resources manager of Bodisen
International, Inc. He received a Bachelor's degree in business management from
ShaanXi Baoji Arts & Sciences Institute in 1999.

COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT

Since we are governed under Section 15(d) of the Exchange Act, we are not
required to file reports of executive officers and directors and persons who own
more than 10% of a registered class of our equity securities pursuant to Section
16(a) of the Exchange Act.


                                        9
<PAGE>
ITEM 10. EXECUTIVE COMPENSATION.

The following table sets forth certain compensation paid or accrued by us to
certain of our executive officers during fiscal years ended 2003, 2002 and 2001.
Summary Compensation Table
<TABLE>
<CAPTION>
                                                                           Other
                                                           Annual      Restricted     Options       LTIP
  Name & Principal                Salary       Bonus       Compen-        Stock         SARs       Payouts      All Other
      Position          Year        ($)         ($)      sation ($)    Awards ($)      (#)(1)        ($)      Compensation
--------------------- --------- ------------ ----------- ------------ -------------- ----------- ------------ --------------
<S>                        <C>           <C>         <C>          <C>          <C>          <C>           <C>      <C>    <C>
Derek Wasson,              2003          0           0            0            0            0             0        32,694 (3)
CEO                        2002          0           0            0            0            0             0        19,047 (3)
                           2001 (1)      0           0            0            0            0             0             0
--------------------- --------- ------------ ----------- ------------ -------------- ----------- ------------ --------------

Steven Bruk,
CEO                        2001 (2)      0           0            0            0            0             0             0

--------------------- --------- ------------ ----------- ------------ -------------- ----------- ------------ --------------
</TABLE>
(1) For the period  January 25, 2001 to December  31,  2001.
(2) For the period January  1,  2001 to  January  25,  2001.
(3) Represents consulting fees paid.

OPTIONS

No options were exercised or granted during the last fiscal year.

There were no long-term incentive plans or rewards made in fiscal 2003.

Employment Agreements

None.

                                       10
<PAGE>
ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICAL OWNERS AND MANAGEMENT.

As of March 22, 2004, there were 15,268,000 shares of common stock, par value
$0.0001 outstanding. The following table sets forth certain information
regarding the beneficial ownership of our common stock as of March 22, 2004:

     -    all directors
     -    each person who is known by us to be the beneficial owner of more than
          five percent (5%) of the outstanding common stock
     -    each executive officer named in the Summary Compensation Table
     -    all directors and executive officers as a group

The number of shares beneficially owned by each director or executive officer is
determined under rules of the SEC, and the information is not necessarily
indicative of beneficial ownership for any other purpose. Under the SEC rules,
beneficial ownership includes any shares as to which the individual has the sole
or shared voting power or investment power. In addition, beneficial ownership
includes any shares that the individual has the right to acquire within 60 days.
Unless otherwise indicated, each person listed below has sole investment and
voting power (or shares such powers with his or her spouse). In certain
instances, the number of shares listed includes (in addition to shares owned
directly), shares held by the spouse or children of the person, or by a trust or
estate of which the person is a trustee or an executor or in which the person
may have a beneficial interest.



Title of Class    Name and Address                 Amount of        Percent of
                  of Beneficial Owner              Beneficial         Class
                                                   Ownership           (1)

Common Stock      Qiong Wang                          3,748,780         24.6%
                  Bodisen Biotech, Inc.,
                  North Part of Xinquia Road,
                  Yang Ling Agricultural High-Tech
                  Industries Demonstration Zone,
                  Yang Ling, China 712100.

Common Stock      Dingxiang Yang                              0            0%
                  Bodisen Biotech, Inc.,
                  North Part of Xinquia Road,
                  Yang Ling Agricultural High-Tech
                  Industries Demonstration Zone,
                  Yang Ling, China 712100.

Common Stock      Yongning Zhang                              0            0%
                  Bodisen Biotech, Inc.,
                  North Part of Xinquia Road,
                  Yang Ling Agricultural High-Tech
                  Industries Demonstration Zone,
                  Yang Ling, China 712100.

Common Stock      Shares of all directors and         3,748,780         24.6%
                  executive officers as a
                  group (3 persons)


Common Stock      Bo Chen                             3,584,096         23.5%
                  Bodisen Biotech, Inc.,
                  North Part of Xinquia Road,
                  Yang Ling Agricultural High-Tech
                  Industries Demonstration Zone,
                  Yang Ling, China 712100.

* Represents less than 1%

(1) Based on 15,268,000 shares of common stock currently outstanding.

                                       11
<PAGE>
STOCK OPTION PLANS

None.


ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.

None.

ITEM 13. EXHIBITS AND REPORTS ON FORM 8-K.

We did not file any reports on Form 8-K during our fourth quarter of 2003.

Exhibits

3.1  Certificate of Incorporation of the Company, filed as Exhibit 3.1 to the
     registration statement on Form SB-2 filed with the Commission on September
     3, 2002 and incorporated herein by reference.

3.2  Amendment to Certificate of Incorporation of the Company, changing name to
     Bodisen Biotech, Inc.

3.3  By-Laws of the of the Company, filed as Exhibit 3.2 to the registration
     statement on Form SB-2 filed with the Commission on September 3, 2002 and
     incorporated herein by reference.

10.1 Consulting Agreement with Big Sky Management, Ltd., filed as Exhibit 10.1
     to the registration statement on Form SB-2 filed with the Commission on
     September 3, 2002 and incorporated herein by reference.

10.2 Loan Agreement, dated as of September 28, 2003, between the Company and
     Xianyang City Commercial Bank

31.1 Certification by Chief Executive Officer pursuant to Sarbanes-Oxley Section
     302.

31.2 Certification by Chief Financial Officer pursuant to Sarbanes-Oxley Section
     302.

32.1 Certification by Chief Executive Officer pursuant to 18 U.S. C. Section
     1350.

32.2 Certification by Chief Financial Officer pursuant to 18 U.S. C. Section
     1350.


                                       12
<PAGE>
                                   SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                                   Bodisen Biotech, Inc., a Delaware Corporation



Dated: March 30, 2004                       By: /s/ Qiong Wang
                                            ----------------------
                                                    Qiong Wang
                                                    Chief Executive Officer

Dated: March 30, 2004                       By: /s/ Dingxiang Yang
                                            ----------------------
                                                    Dingxiang Yang
                                                    Chief Financial Officer


In accordance with the Exchange Act, this report has been signed below by the
following persons on behalf of the registrant and in the capacities and on the
dates indicated.

Signature                    Title                                    Date




/s/ Qiong Wang           Chief Executive Officer                  March 30, 2004
----------------         and Director
    Qiong Wang